Optimising Renal Tumour Management Through Artificial Intelligence Modules — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Optimising Renal Tumour Management Through Artificial Intelligence Modules — Stella

Home/Renal Neoplasms/

View on ClinicalTrials.gov

Recruiting

Back to Renal Neoplasms trials

Trial locations(1 site)

China

The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People's Hospital), Nanjing, Jiangsu

Key details

Sponsor

Shao Pengfei

Enrollment target

~2,100 participants

Started

January 2025

Primary completion

January 2028

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.